- NPMI

Muscat Securities Market (Sultanat of Oman)
0.19 Last Update 14/11/2018 14:50 KSA
× lblWarning! {{companyMessage}}
  • :0.19
  • :0.19
  • ('000):50,000
  • (OMR '000):9,450
  • :-0.07


  • 0
  • :1,001
  • :0
  • 52-W L52-W H
    0.19
    0.00000.2
  • 5.50%
  • -


  • 0

  • (OMR):

    0
  • (OMR):190
  • :0
  • Performance Comparison

Activities

National Pharmaceutical Industries Company (NPMI) is a public company, based in Muscat (Oman), and established in February 1996. NPMI is a subsidiary of Oman Investment Fund Holding Co. and is listed on the Muscat Securities Market since January 2005. The company specializes in the production of anti-allergic, anti-inflammatory, antidepressant,and anti-diabetic medications, and also gastrointestinal drugs. It is among the first pharmaceutical formulations manufacturing plant in Sultanate of Oman. It offers lipid lowering, cardio vascular, anti-bacterial, anti-allergic, non-steroidal anti-inflammatory, gastro intestinal, anti-diabetic, anti-depressant, and analgesic anti-pyretic products too. The company also operates worldwide in almost 12 countries and has a business base in the Gulf and Middle East counties for almost a decade. The company's facilities are spread over a 30,042.43 square meters plot of land, and includes a non-beta lactum plant for producing oral solids, liquids, drops, dry suspensions and sachets; a beta lactum plant, which engages in production of capsules and dry suspension; a research and development laboratory, and a quality control laboratory.

  • Chairman:
    Ghazi O. Al Zubeidi
  • Vice-chairman:
    Abdullah M. B. Al Qenaei
  • CEO:
    G . Sridhar
  • Board Members:

    Amal S. Bahwan

    Khalifa S. Al Mohannadi

    Mahmoud A. Zubaid

    Omar S. Bahwan

  • Auditors:

    Moore Stephens

CMA clears OMR5m rights issue of National Pharmaceuticals (Times of Oman - 24/12/2017)

National Pharmaceutical Industries Company plans to raise its capital by OMR5 million by way of a ...

Read More ...

Read More ...
Announced On Period As Of Net Profit (SAR Mil) Growth (%)
15/10/2018 9-Month 30/09/2018 01 25
12/04/2018 3-Month 31/03/2018 00 16.39
14/01/2018 12-Month 31/12/2017 02 21.33
12/10/2017 9-Month 30/09/2017 01 7.05
12/07/2017 6-Month 30/06/2017 01 -9.96
Market Cap
US$ Mil
Last Price
Local Cry
Price Change (%)
1 Day
Price Change (%)
1 Year
P/E TTM P/B MRQ Dividend Yield (%) Beta ROA (%) ROE (%)
MOUASAT 1,958.78 74.1 0.81 -9.26 19.69 2.64 2.02 0.77 13.85 22.49
SPIMACO 933.82 28.95 -0.86 2.35 27.03 1.33 3.44 0.91 8.47 15.11
DALLAHHEALTH 913.54 58 -0.18 -44.77 19.88 2.11 4.29 0.9 12.1 17.53
MEAHCO 809.45 32.9 -0.31 -34 13.84 1.86 6.01 0.78 11.92 18.76
JULPHAR 642.96 2.1 0 -14.63 29.75 1.02 5.27 0.19 4.09 0
ATC.KSE 541.37 1,100 0 0 18.46 3.34 1.82 -0.01 2.93 12.88
CARE 525.91 44.1 0.22 28.88 24.49 2.04 2.28 0.86 -0.59 -0.89
MCGS 473.61 61.69 -0.18 13.35 20.58 1.74 5.93 0.94 6.76 7.99
GMPC 370.98 1.95 0 -11.36 30.85 1.04 3 -0.08 75.81 111.42
YIACO 76.4 128 0 -26.86 -19.16 2.38 0 0.13 -8.47 -63.6
NPMI 24.5 0.19 0 67.26 5.05 1.2 11.67 -0.07 6.11 0
QGMD 14.03 4.4 -1.35 -18.91 -2.47 0.74 0 0.8 -6.18 0